This paper introduces the Morphogenic Tension Principle (MTP), an original theoretical framework proposing a universal law that governs the dynamic equilibrium of multicellular biological systems through the perpetual opposition between two fundamental forces: the morphogenic force, characterized by differentiated and structurally organized cellular activity, and the amorphogenic force, characterized by undifferentiated and proliferative cellular activity. The principle is formally operationalized through the Morphogenic Dominance Index, a scalar ratio of measurable biological parameters that defines quantitative thresholds for systemic health, oncogenic transition, and organismal death. Computational validation against the TCGA pan-cancer dataset, comprising 11,048 samples across 33 cancer types, yielded a composite index achieving an AUC of 0.895 under five-fold cross-validation, with a combined statistical significance of p = 3.12 × 10 to the power of negative 181. The framework extends beyond oncology to encompass neurodegeneration, fibrosis, autoimmunity, and aging, positioning MTP as a unifying systems-level law that subsumes existing descriptive models most notably the Hallmarks of Cancer within a higher-order mechanistic structure. Convergent evidence from developmental biology, differentiation therapy, non-equilibrium thermodynamics, and bacterial oncology research is presented in support of the principle's universal validity, alongside a structured program of empirical predictions for future experimental validation.
Momen Ghazouani (Sat,) studied this question.